@graphtx.bsky.social
Improving the lives of patients with immune-mediated diseases. We combine complex primary disease models with advanced ML to bridge the gap between pre-clinical models and clinical applications. 🌐 graphtx.com ✏️ graphtx.substack.com
Servus Vienna! 🇦🇹 Christophe Boudesco, Graph’s VP Immunology, will be at the 19th International Congress of Immunology (IUIS 2025) in Vienna from 17 - 22 August. Let us know if you’ll be around and let’s talk translational immunology! 🔬🧬
04.08.2025 13:20 — 👍 3 🔁 0 💬 0 📌 0With its strong academic network & public-private partnerships, Vienna takes a leading role in shaping the bio x AI ecosystem. We're excited to be a part of this and to help it grow! 🌿
Great read about the history & scope of biotech in the 🇦🇹 capital. Check it out! ➡️ www.labiotech.eu/in-depth/vie...
After a year of building again in the techbio space, the Graph co-founders have written a deep dive on why precision medicine requires precision data.
➡️ Check it out: graphtx.substack.com/p/precision-...
Meet the team behind Graph and say hello to @kdris.bsky.social, Head of AI! 👋 🦜
Target discovery in immunology is a complex process. Bringing together individuals who have deep knowledge in adjacent domains helps us approach the challenges from multiple angles. ➕✖️
Happy 1st bday, Graph! 🎈 We've gone from an idea to a team of 11 (recruiting #12!), building lab-in-the-loop infrastructure, fueled by $5M in funding & academic collabs. We had a great time celebrating our journey with the team & reflecting on our mission to rebalance dysregulated immune systems! ➕✖️
30.06.2025 11:52 — 👍 7 🔁 2 💬 0 📌 0We're hiring! 📢
Our team is looking for a Quantitative Systems Biologist driving research at the interface of computational and lab biology. 🧪🥼🔍
Want to know more? Reach out to us and apply via the link below! ⬇️
www.linkedin.com/jobs/view/42...
Poster with a portrait photo of Daniel Thomas, MLOps & data engineer for Graph Therapeutics.
Meet the team behind Graph and say hello to Daniel Thomas, MLOps & data engineer! 👋 💬
We’re excited to have you along for the journey! Here’s to discovering better therapeutics for immune-mediated diseases by bridging the gap between biology and machine learning. ➕✖️
💡How are we using disease perturbational modeling & AI to transform the treatment of immunological diseases? In the AWS Health podcast, Graph's co-founder & CEO @gregvladimer.bsky.social talks science, tech, & where the future is headed in target discovery.
🎧 Check out the podcast! ➡️ bit.ly/43b5LAw
Excited to be joining the panel discussion later today! ✨
Mark your calendars! 📅 The @WiMLWorkshop Social returns to @iclrconf!
🗓️ Friday, April 25th, 2025
⏰ 12:30 PM - 2:00 PM
📍 Hall 1 Apex, Singapore Expo
iclr.cc/virtual/2025...
lu.ma/ftdnjnf9
#ICLR2025
Poster of news from Graph Therapeutics, the Graph Therapeutics logo in the top right corner, with the headline in the center that reads: Graph Therapeutics awarded EUR 1.1M Deep Tech Seed Financing from the Austria Wirtschafts Service (AWS). A logo of the AWS in on the bottom left hand corner.
A poster of a new story from Graph Therapeutics, with the Graph Therapeutics logo in the top right corner. The body text reads: "Graph has been awarded the Deep Tech Life Science Seed Financing grant from the AWS, an Austrian government program that supports techbio projects based on applied research and development. This program helps advance Graph’s clinically realistic precision immunology platform." The AWS logo is in the bottom right hand corner.
Graph receives the Deep Tech Life Science Seed Financing grant from the Austria Wirthschafts Service (AWS) worth EUR 1.1M! This accelerates our AI-driven platform technology and lab-in-the-loop approach to discover better data, targets, validation & biomarkers for immune & inflammatory diseases. 🎯🧬
24.04.2025 08:24 — 👍 5 🔁 1 💬 0 📌 0
Graph at ICLR 2025 in Singapore from 24 - 28 April. Meet us there!
A portrait of Katherine Driscoll, Head of AI at Graph, standing in front of a blackboard with mathematical formulas.
Hey Singapore, @kdris.bsky.social will be at ICLR 2025 from 24 - 28 April! We’re looking forward to hearing about the latest discoveries in biology, AI, and deep learning. Let us know if you’ll be around! 🇸🇬
22.04.2025 09:13 — 👍 5 🔁 2 💬 0 📌 0
Just came back from the IRB conference in Barcelona on BioxAI. Still amazed by the speed at which (Gen)AI is already transforming comp bio research. Had fun catching up with familiar faces and made new connections. Huge thanks to the organisers for putting up cool program with top-notch line ups!
04.04.2025 13:23 — 👍 6 🔁 1 💬 0 📌 0
Portrait of Professor Berend Snijder with a blue button-down shirt against a blurred concrete background.
📣 Congratulations to Graph scientific co-founder Berend Snijder on his new appointment as Faculty Professor and Research Group Leader at the Botnar Institute of Immune Engineering (BIIE)! Here’s to even more groundbreaking work and discoveries. 🥂💥
➡️ Read more: immune.engineering/news/dr-bere...
A poster for Graph at the AI in Drug Discovery and Biomedicine conference in Barcelona, Spain from 31 March to 2 April, 2025.
A photo of Ize Buphamalai, Principal Scientist at Graph.
¡Hola! 🇪🇸 We’re looking forward to seeing everyone at the @irbbarcelona.org for the AI in Drug Discovery and Biomedicine conference. If you’re around, reach out to @izepb.bsky.social and let's meet up! 👋
24.03.2025 10:10 — 👍 3 🔁 1 💬 0 📌 0
Graph CEO Gregory Vladimer stands at a podium in the center of the BIO-Europe Spring presentation stage with the introductory slide to Graph in the background.
We're back on the circuit at BIO-Europe Spring in Milan! ☕ 🇮🇹
@gregvladimer.bsky.social kicked off the 2nd day with a presentation about Graph, specifically how we combine complex immunological models, multi-modal data, and AI to tackle the drug discovery complexities of immune-mediated diseases. 👏
Graph has been awarded an Austrian Life Sciences grant worth EUR 1.1M from the FFG (Austrian Research Promotion Agency)! This funding helps us continue to develop our lab-in-the-loop AI-driven approach to discover better therapeutics for immune-mediated diseases. 🔬🚀
03.03.2025 15:59 — 👍 3 🔁 1 💬 0 📌 0
Graph at BIO-Europe Spring in Milan, Italy between 17 - 19 March, 2025.
Speaker Gregory Vladimer will present a talk on "Immunology: Graph Therapeutics" on 18 March from 10:45 to 11:00 at the location Coral 1.
Meet Graph's CEO and cofounder Gregory Vladimer.
Anyone around Milan 🇮🇹 from 17 - 19 March? We’ll be there! Come and say Ciao! to our CEO & cofounder @gregvladimer.bsky.social and connect with us at BIO-Europe Spring!
27.02.2025 09:18 — 👍 1 🔁 1 💬 0 📌 0
The organizer Ize Buphamalai giving and introduction to the TechBio Transformers meetup.
A group of around 40 techbio enthusiasts listening to the TBT host Ize Buphamalai give an introduction to the event.
Thanks to @izepb.bsky.social for organizing the first Vienna 🇦🇹 @techbio.bsky.social meetup! What a great way to bring everyone together and to build connections in unexpected places. Dankeschön and until next time! 👏
19.02.2025 22:23 — 👍 7 🔁 2 💬 0 📌 0
Poster for a Graph event: Techbio Transformers x Bits in Bio meetup in Paris, France. 25 February 2026.
Poster for a Graph event: Techbio Transformers x Bits in Bio meetup in Paris, France. 25 February 2026. Meet our Head of AI, Katherine Driscoll at the event.
🔬🧬 AI x bio arrives in Paris! Come say Salut! to Graph's @kdris.bsky.social & the techbio community for the @techbio.bsky.social x @bitsinbio.bsky.social meetup, co-hosted with ORAKL Oncology, Speedinvest, & BioLabs. 25 Feb @ 18:30. Join the waitlist: lu.ma/3vavwseg
17.02.2025 07:48 — 👍 6 🔁 3 💬 0 📌 1
Graph Therapeutics announces the closing of a $3.1M pre-seed round aimed at bringing the precision medicine paradigm to inflammation and immunology (I&I). 🚀🔬🧬
Looking forward to great things to come!
Read more ➡️ graphtx.com/news#graph-p...
